Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Canada
0
South Africa
0
Listed Dossiers
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. (r)-(4,4-bis(3-methyl-2-thienyl)-3-butenyl)-3-piperidinecarboxylic Acid, Hydrochloride
2. Gabitril
3. N-(4,4-di(3-methylthien-2-yl)but-3-enyl)nipecotic Acid
4. No 328
5. No 329
6. No-328
7. No-329
8. Tiagabine
9. Tiagabine, (s)-isomer
1. 145821-59-6
2. Tiagabine Hcl
3. Gabitril
4. Abbott 70569.hcl
5. Abbott-70569.1
6. Nnc-05-0328
7. No-05-0328
8. (r)-1-(4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl)piperidine-3-carboxylic Acid Hydrochloride
9. Abt-569
10. Tiagabine (hydrochloride)
11. Tgb Hydrochloride
12. Abbott-70569.hcl
13. Gabitril Hydrochloride
14. No328 Hydrochloride
15. Dqh6t6d8oy
16. No050328 Hydrochloride
17. Abbott-705691
18. Chebi:85388
19. Abbott-70569 Hydrochloride
20. Nnc-050328
21. No-050328
22. Gabitril (tn)
23. 145821-59-6 (hcl)
24. (-)-(r)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]nipecotic Acid Hydrochloride
25. 3-piperidinecarboxylic Acid, 1-(4,4-bis(3-methyl-2-thienyl)-3-butenyl)-, Hydrochloride, (r)-
26. Dsstox_cid_24218
27. Dsstox_rid_80125
28. Dsstox_gsid_44218
29. (3r)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic Acid;hydrochloride
30. (3r)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl]piperidine-3-carboxylic Acid Hydrochloride
31. Cas-145821-59-6
32. Tiagabine Hydrochloride [usan]
33. Abt 569
34. Ncgc00164626-01
35. Unii-dqh6t6d8oy
36. Tiabex
37. (-)-(r)-1-(4,4-bis(3-methyl-2-thienyl)-3-butenyl)nipecotic Acid Hydrochloride
38. Tiagabine Hydrochloride [usan:usp]
39. Mfcd07369025
40. (r)-1-(4,4-bis(3-methylthiophen-2-yl)but-3-enyl)piperidine-3-carboxylic Acid Hydrochloride
41. Tiagabine Monohydrochloride
42. (-)-(r)-1-(4,4-bis(3-methyl-2-thienyl)-3-butenyl)nipecotic Acid, Hydrochloride
43. Chembl1695
44. Schembl41860
45. Mls001401367
46. Tiagabine Hydrochloride (usp)
47. Tiagabine Hydrochloride Solution
48. Dtxsid2044218
49. Hy-b0696a
50. Cep-6671
51. Tiagabine Hydrochloride [mi]
52. Tox21_112245
53. Nn-301
54. No-328
55. S4661
56. Akos024258856
57. Tox21_112245_1
58. Ccg-100885
59. H03t543
60. Ks-1217
61. Nc00135
62. Tiagabine Hydrochloride [mart.]
63. Tiagabine Hydrochloride [vandf]
64. Tiagabine Hydrochloride [usp-rs]
65. Tiagabine Hydrochloride [who-dd]
66. Ncgc00164626-02
67. 3-piperidinecarboxylic Acid, 1-(4,4-bis(3-methyl-2-thienyl)-3-buten-yl)-, Hydrochloride, (r)-
68. 3-piperidinecarboxylic Acid, 1-[4,4-bis(3-methyl-2-thienyl)-3-buten-1-yl]-, Hydrochloride (1:1), (3r)-
69. Smr000469176
70. Tiagabine Hydrochloride, >=98% (hplc)
71. T3165
72. Tiagabine Hydrochloride [orange Book]
73. Ethanone, 1-imidazo[1,2-b]pyridazin-3-yl-
74. C72768
75. D02097
76. Tiagabine Hydrochloride [usp Monograph]
77. A-70569
78. A884577
79. J-008159
80. Q27158534
81. Z2216208631
82. Tiagabine Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
83. (3r)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic Acid Hydrochloride
84. (3r)-1-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]-3-carboxypiperidinium Chloride
85. (3r)-1-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]piperidine-3-carboxylic Acid Hydrochloride
86. (3r)-1-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]piperidine-3-carboxylic Acid Monohydrochloride
87. (r)-1-(4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl)piperidine-3-carboxylicacidhydrochloride
88. Tiagabine Hydrochloride Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
Molecular Weight | 412.0 g/mol |
---|---|
Molecular Formula | C20H26ClNO2S2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 6 |
Exact Mass | 411.1093491 g/mol |
Monoisotopic Mass | 411.1093491 g/mol |
Topological Polar Surface Area | 97 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 474 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Gabitril |
PubMed Health | Tiagabine (By mouth) |
Drug Classes | Anticonvulsant |
Drug Label | GABITRIL (tiagabine HCl) is an antiepilepsy drug available as 2 mg, 4 mg, 12 mg, and 16 mg tablets for oral administration. Its chemical name is (-)-(R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid hydrochloride, its molecular formula is... |
Active Ingredient | Tiagabine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 4mg; 12mg; 2mg; 16mg |
Market Status | Prescription |
Company | Cephalon |
2 of 4 | |
---|---|
Drug Name | Tiagabine hydrochloride |
Drug Label | GABITRIL (tiagabine HCl) is an antiepilepsy drug available as 2 mg, 4 mg, 12 mg, and 16 mg tablets for oral administration. Its chemical name is (-)-(R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid hydrochloride, its molecular formula is... |
Active Ingredient | Tiagabine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 4mg; 2mg |
Market Status | Prescription |
Company | Sun Pharm Inds |
3 of 4 | |
---|---|
Drug Name | Gabitril |
PubMed Health | Tiagabine (By mouth) |
Drug Classes | Anticonvulsant |
Drug Label | GABITRIL (tiagabine HCl) is an antiepilepsy drug available as 2 mg, 4 mg, 12 mg, and 16 mg tablets for oral administration. Its chemical name is (-)-(R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid hydrochloride, its molecular formula is... |
Active Ingredient | Tiagabine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 4mg; 12mg; 2mg; 16mg |
Market Status | Prescription |
Company | Cephalon |
4 of 4 | |
---|---|
Drug Name | Tiagabine hydrochloride |
Drug Label | GABITRIL (tiagabine HCl) is an antiepilepsy drug available as 2 mg, 4 mg, 12 mg, and 16 mg tablets for oral administration. Its chemical name is (-)-(R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid hydrochloride, its molecular formula is... |
Active Ingredient | Tiagabine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 4mg; 2mg |
Market Status | Prescription |
Company | Sun Pharm Inds |
Anticonvulsants
Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)
GABA Uptake Inhibitors
Compounds that suppress or block the plasma membrane transport of GAMMA-AMINOBUTYRIC ACID by GABA PLASMA MEMBRANE TRANSPORT PROTEINS. (See all compounds classified as GABA Uptake Inhibitors.)
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Tiagabine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tiagabine Hydrochloride, including repackagers and relabelers. The FDA regulates Tiagabine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tiagabine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tiagabine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tiagabine Hydrochloride supplier is an individual or a company that provides Tiagabine Hydrochloride active pharmaceutical ingredient (API) or Tiagabine Hydrochloride finished formulations upon request. The Tiagabine Hydrochloride suppliers may include Tiagabine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Tiagabine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tiagabine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Tiagabine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Tiagabine Hydrochloride DMFs exist exist since differing nations have different regulations, such as Tiagabine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tiagabine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Tiagabine Hydrochloride USDMF includes data on Tiagabine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tiagabine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tiagabine Hydrochloride suppliers with USDMF on PharmaCompass.
A Tiagabine Hydrochloride written confirmation (Tiagabine Hydrochloride WC) is an official document issued by a regulatory agency to a Tiagabine Hydrochloride manufacturer, verifying that the manufacturing facility of a Tiagabine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Tiagabine Hydrochloride APIs or Tiagabine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Tiagabine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Tiagabine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tiagabine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tiagabine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tiagabine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tiagabine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tiagabine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tiagabine Hydrochloride suppliers with NDC on PharmaCompass.
Tiagabine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tiagabine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tiagabine Hydrochloride GMP manufacturer or Tiagabine Hydrochloride GMP API supplier for your needs.
A Tiagabine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Tiagabine Hydrochloride's compliance with Tiagabine Hydrochloride specifications and serves as a tool for batch-level quality control.
Tiagabine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Tiagabine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tiagabine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Tiagabine Hydrochloride EP), Tiagabine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tiagabine Hydrochloride USP).
LOOKING FOR A SUPPLIER?